Unsere innovativen Medikamente sollen für Krebspatienten verträglicher und wirksamer als bisherige Therapien sein und eine bessere Lebensqualität bieten.
Location: Germany, Bavaria, Planegg
Employees: 51-200
Total raised: $71.49M
Founded date: 1997
Investors 2
| Date | Name | Website |
| - | Heidelberg... | heidelberg... |
| - | Wellington... | wellington... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.11.2019 | - | $24.66M | - |
| 06.07.2017 | - | $46.83M | - |
Mentions in press and media 1
| Date | Title | Description |
| 06.07.2017 | 4SC secures EUR 41 million from successful capital increase | 4SC AG announced the completion of its capital increase resolved on 12 June 2017 to continue to advance its drug development programs for resminostat, 4SC-202 and 4SC-208. |